bf/NASDAQ:BMRN_icon.png

NASDAQ:BMRN

BioMarin Pharmaceutical Inc.

  • Stock

USD

Last Close

83.80

03/05 20:00

Market Cap

17.12B

Beta: 0.38

Volume Today

1.60M

Avg: 1.37M

PE Ratio

112.42

PFCF: 528.69

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
145.65M
-
181.03M
24.29%
235.57M
30.13%
313.40M
33.04%
415.45M
32.56%
503.32M
21.15%
605.57M
20.31%
689.41M
13.84%
737.61M
6.99%
835.38M
13.25%
average payables
121.19M
-
165.52M
36.58%
314.13M
89.78%
381.51M
21.45%
386.21M
1.23%
419.61M
8.65%
503.96M
20.10%
381.02M
24.39%
192.22M
49.55%
212.12M
10.36%
average receivables
113.44M
-
131.15M
15.61%
154.72M
17.97%
190.12M
22.88%
238.32M
25.35%
302.00M
26.72%
360.02M
19.21%
412.88M
14.68%
410.88M
0.49%
417.36M
1.58%
book value per share
9.73
-
10.44
7.24%
15.00
43.71%
16.67
11.08%
16.10
3.38%
16.76
4.10%
17.44
4.04%
22.71
30.22%
23.36
2.85%
24.85
6.38%
capex per share
-0.47
-
-0.81
71.76%
-1.42
75.20%
-0.89
37.16%
-1.14
27.76%
-0.82
28.49%
-0.91
11.74%
-0.76
16.66%
-0.65
14.27%
-0.71
8.89%
-0.50
28.92%
capex to depreciation
-1.38
-
-2.09
51.99%
-4.82
130.37%
-1.53
68.26%
-2.27
48.09%
-1.51
33.33%
-1.55
2.66%
-1.31
15.74%
-1.10
15.60%
-1.29
16.90%
-1.02
21.23%
capex to operating cash flow
1.09
-
1.62
47.97%
1.03
36.45%
0.65
36.58%
22.75
3,393.21%
-7.16
131.46%
-3.39
52.69%
-1.61
52.42%
-0.39
75.70%
-0.75
91.01%
-0.61
18.81%
capex to revenue
-0.12
-
-0.16
33.26%
-0.26
61.68%
-0.13
48.07%
-0.15
14.15%
-0.10
36.05%
-0.10
1.12%
-0.07
22.92%
-0.06
12.64%
-0.06
2.82%
-0.04
36.31%
cash per share
5.70
-
6.46
13.38%
3.70
42.66%
4.76
28.47%
8.00
68.22%
6.12
23.48%
4.21
31.25%
5.89
39.95%
5.54
5.90%
6.97
25.73%
days of inventory on hand
619.90
-
561.02
9.50%
652.36
16.28%
618.36
5.21%
718.23
16.15%
614.62
14.43%
690.75
12.39%
486.33
29.59%
602.50
23.89%
674.72
11.99%
days payables outstanding
363.32
-
663.09
82.51%
942.49
42.14%
645.14
31.55%
606.74
5.95%
506.28
16.56%
579.41
14.44%
133.27
77.00%
149.72
12.34%
174.50
16.55%
days sales outstanding
78.41
-
70.21
10.45%
67.66
3.64%
70.36
3.98%
72.62
3.22%
83.87
15.48%
80.84
3.61%
87.96
8.81%
73.82
16.08%
80.33
8.82%
debt to assets
0.29
-
0.26
9.35%
0.18
32.78%
0.17
4.38%
0.25
49.29%
0.19
26.00%
0.18
3.59%
0.19
2.78%
0.18
2.35%
0.17
5.50%
debt to equity
0.49
-
0.43
11.91%
0.28
35.94%
0.25
10.46%
0.42
69.30%
0.28
33.09%
0.27
2.92%
0.26
2.55%
0.26
3.62%
0.24
6.89%
dividend yield
earnings yield
-0.02
-
-0.01
44.35%
-0.01
1.20%
-0.05
347.24%
-0.01
83.58%
-0.01
31.94%
-0.00
69.24%
0.05
3,539.50%
-0.00
107.32%
0.01
286.14%
0.01
22.91%
enterprise value
9.78B
-
13.01B
33.08%
17.03B
30.87%
14.03B
17.64%
16.13B
15.01%
15.41B
4.44%
15.55B
0.88%
16.28B
4.71%
16.65B
2.25%
19.53B
17.33%
enterprise value over ebitda
-82.31
-
-94.46
14.76%
-59.28
37.24%
-72.88
22.95%
-224.98
208.68%
-153.75
31.66%
-699.03
354.66%
-2.78K
298.13%
346.62
112.45%
122.44
64.67%
ev to operating cash flow
-163.96
-
-176.95
7.92%
-76.82
56.59%
-61.56
19.86%
-1.84K
2,892.26%
762.73
141.41%
322.17
57.76%
190.72
40.80%
54.66
71.34%
111.04
103.13%
ev to sales
17.83
-
17.33
2.81%
19.14
10.45%
12.56
34.38%
12.28
2.22%
10.34
15.82%
9.12
11.72%
8.75
4.09%
9.02
3.03%
9.32
3.35%
free cash flow per share
-0.91
-
-1.31
45.14%
-2.81
113.62%
-2.27
19.28%
-1.19
47.39%
-0.70
41.07%
-0.64
8.47%
-0.29
55.15%
1.01
451.34%
0.24
76.37%
0.33
36.38%
free cash flow yield
-0.01
-
-0.01
12.95%
-0.03
84.33%
-0.03
2.08%
-0.01
51.13%
-0.01
38.29%
-0.01
7.82%
-0.00
56.75%
0.01
448.71%
0.00
79.83%
0.00
46.38%
graham net net
0.34
-
1.30
288.42%
-2.98
328.42%
-0.78
73.95%
0.03
104.01%
0.83
2,582.83%
-1.06
227.81%
0.05
104.63%
-0.28
658.80%
1.69
713.15%
graham number
16.75
-
14.66
12.43%
19.04
29.82%
37.73
98.21%
15.59
58.68%
12.82
17.75%
7.23
43.63%
49.27
581.56%
13.57
72.46%
20.67
52.30%
income quality
0.34
-
0.55
62.33%
1.29
135.08%
0.36
71.98%
0.07
79.30%
-0.26
449.81%
-2.02
673.23%
0.10
104.91%
-4.75
4,882.78%
1.24
126.15%
0.95
23.55%
intangibles to total assets
0.10
-
0.08
12.42%
0.24
179.06%
0.19
21.01%
0.15
17.35%
0.16
0.89%
0.14
10.43%
0.10
24.73%
0.10
7.13%
0.08
13.90%
0
100%
interest coverage
-14.93
-
-2.54
83.02%
-2.89
14.18%
-20.34
602.70%
-0.34
98.31%
-2.83
721.88%
-5.35
89.03%
-3.28
38.58%
-3.91
19.14%
3.60
192.09%
-9.12
353.10%
interest debt per share
4.83
-
4.75
1.83%
4.38
7.77%
4.35
0.53%
6.98
60.26%
4.94
29.26%
4.87
1.39%
6.17
26.82%
6.04
2.12%
5.99
0.90%
inventory turnover
0.59
-
0.65
10.50%
0.56
14.00%
0.59
5.50%
0.51
13.90%
0.59
16.86%
0.53
11.02%
0.75
42.03%
0.61
19.28%
0.54
10.70%
invested capital
0.49
-
0.43
11.91%
0.28
35.94%
0.25
10.46%
0.42
69.30%
0.28
33.09%
0.27
2.92%
0.26
2.55%
0.26
3.62%
0.24
6.89%
market cap
9.69B
-
13.23B
36.52%
16.76B
26.71%
13.75B
17.98%
15.55B
13.12%
15.08B
3.07%
15.14B
0.40%
15.85B
4.74%
16.15B
1.89%
19.17B
18.68%
18.47T
96,251.21%
net current asset value
229.24M
-
463.07M
102.00%
-238.88M
151.59%
164.38M
168.81%
382.68M
132.81%
597.03M
56.01%
374.49M
37.28%
600.20M
60.27%
541.80M
9.73%
979.54M
80.79%
net debt to ebitda
-0.73
-
1.58
316.12%
-0.92
158.48%
-1.43
54.73%
-8.04
462.79%
-3.36
58.26%
-18.46
450.16%
-72.82
294.40%
10.24
114.06%
2.25
78.05%
net income per share
-1.28
-
-0.92
28.49%
-1.07
17.28%
-3.80
253.66%
-0.67
82.33%
-0.44
35.01%
-0.13
69.45%
4.75
3,667.23%
-0.35
107.38%
0.76
318.03%
0.87
14.51%
operating cash flow per share
-0.43
-
-0.50
16.08%
-1.39
175.69%
-1.37
0.92%
-0.05
96.34%
0.11
327.33%
0.27
136.19%
0.47
75.15%
1.67
252.75%
0.95
42.99%
0.83
12.45%
payables turnover
1.00
-
0.55
45.21%
0.39
29.65%
0.57
46.09%
0.60
6.33%
0.72
19.84%
0.63
12.62%
2.74
334.75%
2.44
10.99%
2.09
14.20%
receivables turnover
4.66
-
5.20
11.67%
5.39
3.77%
5.19
3.83%
5.03
3.12%
4.35
13.41%
4.52
3.74%
4.15
8.10%
4.94
19.16%
4.54
8.11%
research and ddevelopement to revenue
0.65
-
0.61
4.99%
0.71
16.08%
0.59
16.92%
0.46
21.55%
0.47
0.44%
0.42
10.14%
0.34
19.54%
0.34
0.88%
0.31
9.00%
0.31
0.40%
return on tangible assets
-0.09
-
-0.06
32.29%
-0.06
2.63%
-0.19
219.25%
-0.03
84.49%
-0.02
30.85%
-0.01
71.39%
0.16
2,877.85%
-0.01
107.21%
0.02
304.96%
revenue per share
3.98
-
5.13
28.89%
5.56
8.36%
6.73
21.00%
7.53
11.93%
8.42
11.83%
9.52
13.01%
10.29
8.11%
10.10
1.87%
11.31
12.05%
12.63
11.61%
roe
-0.13
-
-0.09
33.32%
-0.07
18.39%
-0.23
218.37%
-0.04
81.71%
-0.03
37.57%
-0.01
70.64%
0.21
2,839.42%
-0.02
107.17%
0.03
304.96%
roic
-0.08
-
-0.05
41.60%
-0.04
11.99%
-0.18
340.14%
-0.01
93.18%
-0.02
46.13%
-0.01
54.95%
0.38
4,836.50%
-0.01
102.53%
0.01
200.43%
sales general and administrative to revenue
0.43
-
0.40
6.24%
0.45
12.36%
0.43
5.60%
0.42
1.11%
0.41
3.96%
0.18
-
0.19
6.80%
0.19
0.37%
shareholders equity per share
9.73
-
10.44
7.24%
15.00
43.71%
16.67
11.08%
16.10
3.38%
16.76
4.10%
17.44
4.04%
22.71
30.22%
23.36
2.85%
24.85
6.38%
stock based compensation to revenue
0.12
-
0.12
2.64%
0.13
6.68%
0.12
3.81%
0.11
11.43%
0.10
6.53%
0.09
5.99%
0.10
8.69%
0.11
4.78%
0.09
12.34%
0.09
8.60%
tangible asset value
1.12B
-
1.32B
17.21%
1.52B
15.39%
2.02B
32.61%
2.09B
3.90%
2.28B
8.83%
2.47B
8.32%
3.49B
41.47%
3.69B
5.54%
4.07B
10.38%
tangible book value per share
8.16
-
9.00
10.33%
9.50
5.53%
12.14
27.85%
12.01
1.13%
12.87
7.21%
13.79
7.13%
19.32
40.09%
20.16
4.35%
21.96
8.94%
working capital
954.15M
-
1.19B
24.71%
644.18M
45.86%
982.48M
52.52%
1.39B
41.54%
1.53B
10.24%
1.01B
34.14%
1.85B
83.20%
1.73B
6.22%
2.16B
24.68%

All numbers in USD (except ratios and percentages)